A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

Background: Findings regarding the prevalence of vascular comorbidities in multiple sclerosis (MS) are conflicting. Objective: The objective of this review is to estimate the incidence and prevalence of vascular comorbidities and predisposing comorbidities in persons with MS and to assess the quality of the included studies. Methods: The PubMed, EMBASE, SCOPUS and Web of Knowledge databases, conference proceedings, and reference lists of retrieved articles were searched. One reviewer abstracted data using a standardized data collection form, while the second reviewer verified the abstraction. Included studies were assessed qualitatively. Quantitatively, we assessed studies using the I2 statistic, and conducted meta-analyses for population-based studies only. Results: The prevalence of hypertension and hyperlipidemia exceeded 10% in the MS population and increased with age. While the prevalence of ischemic heart disease, congestive heart failure, and stroke were less than 5% overall, the prevalence of these conditions exceeded expectations when compared to the general population. Cardiac valvular disease, however, affected the MS population less often than expected. Problems with study quality were common. Conclusion: Despite the relatively high prevalence of some vascular comorbidities in the MS population, important gaps exist in our understanding of their epidemiology. Most of our knowledge is based on studies conducted in a small number of regions.

• Publication year

  2015

• Venue

  Multiple Sclerosis

• Publication date

  2015-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1352458514564485PMID 25533300PMCID 4404402
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Continuity Correction

  2017cited by this paper
• The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

  2015cited by this paper
• A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

  2015cited by this paper
• The Global Burden of Ischemic Heart Disease in 1990 and 2010: The Global Burden of Disease 2010 Study

  2014cited by this paper
• Increased breast cancer risk for patients with multiple sclerosis: a nationwide population‐based cohort study

  2014cited by this paper
• Increased breast cancer risk for patients with multiple sclerosis: a nationwide population-based cohort study.

  2014cited by this paper
• Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.

  2014cited by this paper
• Neurological comorbidity and survival in multiple sclerosis.

  2014cited by this paper
• Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

  2013cited by this paper
• Association between multiple sclerosis and chronic periodontitis: a population‐based pilot study

  2013cited by this paper
• Comorbidities at multiple sclerosis diagnosis

  2013cited by this paper
• High risk of cardiovascular diseases after diagnosis of multiple sclerosis

  2013cited by this paper
• Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study.

  2013cited by this paper
• Valvular heart disease: classic teaching and emerging paradigms.

  2013cited by this paper
• Impact of comorbidity on fatigue management intervention outcomes among people with multiple sclerosis: an exploratory investigation.

  2013cited by this paper
• Birth hospitalization in mothers with multiple sclerosis and their newborns

  2013cited by this paper
• Chronic Diseases in Male Veterans With Multiple Sclerosis

  2012cited by this paper
• Causes of death in patients with multiple sclerosis and matched referent subjects: a population‐based cohort study

  2012cited by this paper
• Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia

  2012cited by this paper
• Statin therapy and multiple sclerosis disability in a population-based cohort

  2012cited by this paper
• Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis

  2012cited by this paper
• Substantial adverse association of visual and vascular comorbidities on visual disability in multiple sclerosis

  2011cited by this paper
• Vascular dysfunction and physical activity in multiple sclerosis.

  2011cited by this paper
• Association between comorbidity and clinical characteristics of MS

  2011cited by this paper
• Risk of Arterial Cardiovascular Diseases in Patients with Multiple Sclerosis: A Population-Based Cohort Study

  2010cited by this paper
• Autonomic Dysfunction Presenting as Postural Orthostatic Tachycardia Syndrome in Patients with Multiple Sclerosis

  2010cited by this paper
• Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

  2010cited by this paper
• Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study

  2010cited by this paper
• Comorbidities amongst patients with multiple sclerosis: a population‐based controlled study

  2010cited by this paper
• Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece

  2010cited by this paper
• Validation of a Self-Report Comorbidity Questionnaire for Multiple Sclerosis

  2010cited by this paper
• Factors influencing the health-related quality of life in Hungarian multiple sclerosis patients.

  2010cited by this paper
• Long-term effect of comorbidity on the course of physical functioning in patients after stroke and with multiple sclerosis.

  2009cited by this paper
• Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modelling.

  2009cited by this paper
• Comorbidity and Health-Related Quality of Life in People with Multiple Sclerosis

  2009cited by this paper
• Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review.

  2009cited by this paper
• Characterization of functioning in multiple sclerosis using the ICF

  2009cited by this paper
• Stroke surveillance in Manitoba, Canada: estimates from administrative databases.

  2008cited by this paper
• Vascular Disease among Hospitalized Multiple Sclerosis Patients

  2008cited by this paper
• Comorbidity, socioeconomic status and multiple sclerosis

  2008cited by this paper
• Population-based data sources for chronic disease surveillance.

  2008cited by this paper
• Epidemiology of autoimmune diseases in Denmark.

  2007cited by this paper
• Familial clustering of multiple sclerosis in a Dutch genetic isolate

  2007cited by this paper
• Autoimmune disease in families with multiple sclerosis: a population-based study.

  2007cited by this paper
• Caregiver strain and factors associated with caregiver self-efficacy and quality of life in a community cohort with multiple sclerosis

  2007cited by this paper
• Factors Associated with Health-Related Quality of Life in Multiple Sclerosis

  2007cited by this paper
• Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study.

  2006cited by this paper
• Multiple sclerosis and autoimmune diseases

  2006cited by this paper
• Demographic and Disease Characteristics of People With Multiple Sclerosis Living in Urban and Rural Areas

  2006cited by this paper
• Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study.

  2006cited by this paper
• Prevalence of Diabetes in Patients With Multiple Sclerosis

  2006cited by this paper
• Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review.

  2006cited by this paper
• Risk of myocardial infarction in patients with psoriasis.

  2006cited by this paper
• How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease?

  2005cited by this paper
• A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic

  2004cited by this paper
• An association between multiple sclerosis and type I diabetes mellitus

  2004cited by this paper
• The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone.

  2004cited by this paper
• Asthma and multiple sclerosis: an inverse association in a case-control general practice population.

  2002cited by this paper
• Patients with multiple sclerosis and risk of type 1 diabetes mellitus in Sardinia, Italy: a cohort study.

  2002cited by this paper
• The occurrence of autoimmune diseases in patients with multiple sclerosis and their families.

  2000cited by this paper
• Coding accuracy of hospital discharge data for elderly survivors of myocardial infarction.

  1999cited by this paper
• Multiple sclerosis and chronic inflammatory diseases A case‐control study

  1996cited by this paper
• Multiple sclerosis as a comorbidity: a study of resource utilization and outcomes of care.

  1995cited by this paper
• Multiple sclerosis as a comorbidity: a study of resource utilization and outcomes of care.

  1995cited by this paper
• Patterns of comorbidity in elderly patients with multiple sclerosis.

  1994cited by this paper
• An association between multiple sclerosis and diabetes mellitus

  1992cited by this paper
• A reappraisal of the epidemiology of multiple sclerosis in Olmsted County, Minnesota

  1990cited by this paper
• Multiple sclerosis and other immunologic diseases

  1990cited by this paper
• Autoimmunity in multiple sclerosis

  1988cited by this paper
• Diseases associated with multiple sclerosis and epilepsy

  1985cited by this paper
• Malignant diseases among patients with multiple sclerosis

  1977cited by this paper
• BMC Medical Genetics BioMed Central Research article Genetic loci linked to Type 1 Diabetes and Multiple Sclerosis families in Sardinia

  year unknowncited by this paper

• The Framingham score is a marker of early disability progression in multiple sclerosis.

  2026cites this paper
• Comorbidity and modifiable risk factors in multiple sclerosis

  2026influential citation
• Comorbidity and cardiovascular risk factors in multiple sclerosis

  2025cites this paper
• Recognizing and Addressing Mental Health Comorbidities in Hypertension Care Strategies: A Narrative Review

  2025cites this paper
• Performance of a Modified Version of the Charlson Comorbidity Index in Predicting Multiple Sclerosis Disability Accrual.

  2025cites this paper
• Unmasking the Silent Threat: Prevalence of Cardiovascular Risk Factors in MS Patients in Bucharest, Romania

  2025cites this paper
• Early comorbidities and diagnostic challenges in people with multiple sclerosis with possible impact on disease management

  2025cites this paper
• Dietary habits and advanced imaging/laboratory markers in multiple sclerosis: An exploratory cross-sectional study

  2025cites this paper
• Multiple sclerosis pathophysiology: a comprehensive review of genetic, environmental, and immunological drivers

  2025cites this paper
• Plasma tissue factor as a promising marker in multiple sclerosis: Evidence from a two-sample Mendelian randomization study

  2025cites this paper
• Differences in upper and lower limb function in persons with multiple sclerosis with vascular comorbidities.

  2025cites this paper
• Changes in peripapillary and macular vasculature measured by optical coherence tomography angiography and their clinical correlation in patients with optic neuritis due to multiple sclerosis

  2024cites this paper
• Metabolic syndrome and the phenotype of multiple sclerosis.

  2024cites this paper
• Retinal changes in multiple sclerosis: An optical coherence tomography and angiography study.

  2024cites this paper
• Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations

  2024cites this paper
• Association of multiple sclerosis with stroke: A comprehensive review

  2024cites this paper
• Evaluation of the Vascular Network with Optical Coherens Tomography Angiography in Multiple Sclerosis and its Relationship with the Clinic.

  2024cites this paper
• Cardiovascular hemodynamic response to peak exercise in individuals with multiple sclerosis

  2024cites this paper
• Multiple sclerosis and vascular nexus: A systematic review and meta-analysis of incidence and mortality.

  2024cites this paper
• Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications

  2024cites this paper
• Comorbidities and their association with outcomes in the multiple sclerosis population: A rapid review.

  2024cites this paper
• Associations between the Framingham Risk Score and cognitive functions in people with multiple sclerosis

  2024cites this paper
• Neuroticism as a Common Factor in Depression and Anxiety Associated with Multiple Sclerosis—A Systematic Review and Meta-Analysis

  2024cites this paper
• Vascular function in multiple sclerosis: Systematic review with meta-analysis.

  2024cites this paper
• Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis

  2024cites this paper
• Smouldering‐Associated Worsening in Multiple Sclerosis: An International Consensus Statement on Definition, Biology, Clinical Implications, and Future Directions

  2024cites this paper
• Risk factors and characteristics of new-onset coronary heart disease in adults with physical disabilities: A retrospective cohort study

  2023cites this paper
• Comorbidities in Patients with Multiple Sclerosis and How Lifestyle Behaviors Can Change the Comorbidities, Role of the Family Physician and Neurologist

  2023cites this paper
• Comorbidity in the aging population with multiple sclerosis: a Danish nationwide study

  2023cites this paper
• Systematic review and meta-analysis of sedentary behavior in persons with multiple sclerosis.

  2023cites this paper
• The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review

  2023influential citation
• Anaesthetic management of people with multiple sclerosis.

  2023cites this paper
• Cardiopulmonary exercise testing in people with minimally impaired multiple sclerosis.

  2023cites this paper
• Internal comorbidities and complications of multiple sclerosis therapy - don't be caught off guard!

  2023cites this paper
• Stem Cells Attenuate the Inflammation Crosstalk Between Ischemic Stroke and Multiple Sclerosis: A Review

  2023cites this paper
• Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study

  2023cites this paper
• Endothelial Function in Patients with Multiple Sclerosis: The Role of GLP-1 Agonists, Lipoprotein Subfractions, and Redox Balance

  2023cites this paper
• The risk of dementia in multiple sclerosis and neuromyelitis optica spectrum disorder

  2023cites this paper
• The Heart–Brain Interplay in Multiple Sclerosis from Pathophysiology to Clinical Practice: A Narrative Review

  2023cites this paper
• Prevalence of comorbidities in patients with multiple sclerosis using administrative data from 2007 to 2016 in Iran.

  2023cites this paper
• Microvascular impairments detected by optical coherence tomography angiography in multiple sclerosis patients: A systematic review and meta-analysis

  2023cites this paper
• Myocardial infarction and stroke risks in multiple sclerosis patients: A two-sample Mendelian randomization study.

  2022cites this paper
• Atherosclerosis and multiple sclerosis: An overview on the prevalence of risk factors.

  2022cites this paper
• Autoimmune comorbidities in persons with multiple sclerosis in the population of Belgrade

  2022cites this paper
• Correlation between Retinal Vascularization and Disease Aggressiveness in Amyotrophic Lateral Sclerosis

  2022cites this paper
• Risk of stroke in multiple sclerosis and neuromyelitis optic spectrum disorder: a Nationwide cohort study in South Korea

  2022cites this paper
• Microvascular changes in the macular and parafoveal areas of multiple sclerosis patients without optic neuritis

  2022cites this paper
• Symptom-Level Disability Status Assessed with an Electronic Unsupervised Patient-Reported Expanded Disability Status Scale (ePR-EDSS) in Multiple Sclerosis Patients—The Example of Croatia

  2022cites this paper
• Non-immune system comorbidity in neuromyelitis optica spectrum disorders.

  2022cites this paper
• Acute myocardial infarction risk in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study in South Korea

  2022cites this paper
• Effect of Vascular Comorbidity on Visual and Disability Outcomes in a Secondary Progressive Multiple Sclerosis Clinical Trial Cohort.

  2022cites this paper
• Stroke risk in multiple sclerosis: a critical appraisal of the literature

  2022cites this paper
• Comorbidity in multiple sclerosis: Emphasis on patient-reported outcomes.

  2022cites this paper
• Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis

  2021cites this paper
• CEOR_A_305154 377..394

  2021cites this paper
• Aspectos del estilo de vida en personas con esclerosis múltiple antes y durante la pandemia COVID-19: resultado de una encuesta en Argentina

  2021cites this paper
• Prevalence of comorbidities in multiple sclerosis patients with neurogenic bladder

  2021cites this paper
• Associations between multiple sclerosis and incidence of heart diseases: Systematic review and meta-analysis of observational studies.

  2021cites this paper
• Impact of comorbidities on the disability progression in multiple sclerosis

  2021cites this paper
• Hypertension and hypertension severity in Hispanics/Latinx with MS

  2021cites this paper
• COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications

  2021cites this paper
• Thinking Outside the Ischemia Box: Advancements in the Use of Multiple Sclerosis Drugs in Ischemic Stroke

  2021cites this paper
• Prevalence of comorbidities in multiple sclerosis patients with neurogenic bladder.

  2021cites this paper
• Three-Day Dietary Manipulation in Multiple Sclerosis: Exercise and Fatigue Outcomes.

  2021cites this paper
• Influence of Comorbidities on Healthcare Expenditures and Perceived Physical and Mental Health Status Among Adults with Multiple Sclerosis: A Propensity Score-Matched US National-Level Study

  2020cites this paper
• Comparison of sedentary behaviour questionnaires in people with multiple sclerosis

  2020cites this paper
• Multiple Sclerosis and the Heart

  2020cites this paper
• Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study.

  2020cites this paper
• Impaired heart rate recovery after sub-maximal physical exercise in people with multiple sclerosis.

  2020cites this paper
• Optical coherence tomography angiography findings of multiple sclerosis with or without optic neuritis

  2020influential citation
• Management of diabetes and hypertension in people with multiple sclerosis.

  2020cites this paper
• Comorbid disease burden among MS patients 1968–2012: A Swedish register–based cohort study

  2020cites this paper
• The impact of stroke on psychological and physical function outcomes in people with long-term physical disability.

  2020cites this paper
• Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England.

  2020cites this paper
• Kognitive Funktion als Ziel der Bewegungstherapie bei Multiple Sklerose

  2020cites this paper
• Stress cardiomyopathy associated with the first manifestation of multiple sclerosis: a case report

  2020cites this paper
• Genetic Etiology Shared by Multiple Sclerosis and Ischemic Stroke

  2020cites this paper
• Trends in hospital readmissions in Multiple Sclerosis patients between 2009 and 2015.

  2020cites this paper
• A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications

  2020cites this paper
• Infections in patients with multiple sclerosis: A national cohort study in Sweden.

  2020cites this paper
• Comorbidity in Multiple Sclerosis

  2020cites this paper
• Non-infectious comorbidity in patients with multiple sclerosis: A national cohort study in Sweden

  2020cites this paper
• Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis

  2020cites this paper
• Vascular disease and multiple sclerosis: a post-mortem study exploring their relationships.

  2020cites this paper
• The Incidence of Transverse Sinus Stenosis in Multiple Sclerosis: Further Evidence of Pulse Wave Encephalopathy.

  2020cites this paper
• Multiple sclerosis and COVID‐19: How many are at risk?

  2020cites this paper
• The prevalence of hypertension in multiple sclerosis based on 37 million electronic health records from the United States

  2020cites this paper
• The Framingham cardiovascular risk score and 5‐year progression of multiple sclerosis

  2020cites this paper
• ASSESSMENT OF COMORBIDITY BURDEN IN PERSONS WITH MULTIPLE SCLEROSIS: OBSERVATIONAL STUDY BASED ON BELGRADE POPULATION REGISTRY DATA

  2020cites this paper
• Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study

  2019cites this paper
• Cerebrovascular reactivity and its correlation with age in patients with multiple sclerosis

  2019cites this paper
• Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications

  2019cites this paper
• Assessment of the optic nerve and its arterial supply by ultrasound imaging in multiple sclerosis patients

  2019cites this paper
• HDL-cholesterol elevation associated with fingolimod and dimethyl fumarate therapies in multiple sclerosis

  2019cites this paper
• Evaluating functional electrical stimulation (FES) cycling on cardiovascular, musculoskeletal and functional outcomes in adults with multiple sclerosis and mobility impairment: A systematic review.

  2019cites this paper
• [Comorbid pathology of the cardiovascular system in young patients with relapsing-remitting multiple sclerosis].

  2019cites this paper
• Brugada Syndrome Caused by Autonomic Dysfunction in Multiple Sclerosis

  2019cites this paper
• Effects of comorbidity in persons with multiple sclerosis

  2019influential citation
• Traditional risk factors may not explain increased incidence of myocardial infarction in MS

  2019cites this paper
• Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors

  2019cites this paper